Steven G. Smith

Also affiliated with AstraZeneca (Singapore)

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia”.

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

Nature(2023)10.1038/s41586-023-05812-3

N/A

5.2DataRank · unranked

480 citations

Ibrahim Aldoss, John F. Dipersio, Branko Cuglievan, Richard M. Stone, Martha Arellano +19 more

Real-life effectiveness of mepolizumab in severe asthma: a systematic literature review

Journal of Asthma(2021)10.1080/02770903.2021.2008431

N/A

0.538DataRank · unranked

35 citations

Giorgio Walter Canonica, Guy Brusselle, Shibing Yang, Peter Howarth, Amber Martin +4 more

Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities

Journal of Leukocyte Biology(2024)10.1093/jleuko/qiae051

N/A

0DataRank · unranked

5 citations

Florence Roufosse, Fei Li Kuang, Steven J. Ackerman, Praveen Akuthota, Bruce S. Bochner +68 more